ALTRUBIO
AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. AltruBio International in Delaware with principal office in SFO Bay Area California is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discover... y and development of novel therapeutics for unmet medical needs. Their R&D scientists built an efficient discovery platform to identify and validate novel antibody therapeutics. Currently, AbGenomics has several potential therapeutic antibodies targeting autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors in various development stages.
ALTRUBIO
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2000-06-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.altrubio.com
Total Employee:
11+
Status:
Active
Contact:
(650) 988-9912
Email Addresses:
[email protected]
Total Funding:
102.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
CAM Capital
CAM Capital investment in Series A - AltruBio
aMoon Fund
aMoon Fund investment in Series A - AltruBio
BVF Partners
BVF Partners investment in Series A - AltruBio
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-13 | AltruBio snags a CMO after pivot from oncology to immunology |
| 2021-08-09 | AltruBio Strengthens Management Team With Appointment of Jeroen Grasman as Chief Financial Officer |
Official Site Inspections
http://www.altrubio.com Semrush global rank: 1.78 M Semrush visits lastest month: 13.03 K
Unable to get host informations!!!
